Among a cohort of 1,135 women ages 40 and younger with stage I through III breast cancer, the incidence of LRR was 5.6%, with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Beth Ferguson’s doctor initially said “there was nothing to worry about” after she found a lump on her left breast because ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

A new study has found that a commonly prescribed anti-nausea medication is associated with a better prognosis for women with ...

While the incidence of breast cancer is highest for white women, Black women are more likely to have early-onset or more ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

OneTouch-PAT offers a painless, radiation-free breast cancer screening method that detects tumors in under a minute without ...

Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated ...

A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...